Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The anion gap as a predictive tool for morbidity and mortality61
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting57
The dual roles of microorganisms in inflammatory diseases: initiators and regulators49
Machine learning-based error detection in the clinical laboratory: a critical review47
Data analytics for error detection in clinical laboratories43
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease35
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review34
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application33
Transthyretin mutagenesis: impact on amyloidogenesis and disease32
Single cell mechanodeformation signatures as early biomarkers for hematological malignancies31
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications27
Clinical utility of human epididymis protein 425
Comparison of liquid biopsy-based technologies for cancer screening24
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology24
Cardiovascular disease lipids and lipoproteins biomarker standardization23
Beyond newborn screening: the role of reverse cascade testing in familial disease detection23
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation21
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker21
One health and laboratory medicine: challenges and perspectives for antimicrobial resistance, emerging infections, and food/water security21
Mid-regional pro-atrial natriuretic peptide in managing cardiovascular and cerebrovascular diseases20
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration20
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1919
Challenges of insulin-like growth factor-1 testing19
Blood biomarkers for the diagnosis of chorioamnionitis following preterm premature rupture of membranes: a systematic review and meta-analysis of studies since 202018
Association of inflammatory biomarkers with morbidity and mortality risk in patients with peripheral artery disease: a systematic review and ­meta-analysis18
Omics-based computational approaches for biomarker identification, prediction, and treatment of Long COVID18
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections17
Emerging applications of machine learning in genomic medicine and healthcare16
The intersection of the laboratory and transgender care16
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?15
Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review14
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor12
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis12
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders12
Diagnostic stewardship monitoring systems: institutional and system-level approaches12
Guidelines for diagnosing and differentiating infection with antifungal-resistant Trichophyton indotineae from other dermatophytoses11
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)11
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review11
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?11
0.25813913345337